Sotera Health Company (NASDAQ:SHC) Receives $20.00 Consensus PT from Analysts

Shares of Sotera Health Company (NASDAQ:SHC) have earned a consensus recommendation of “Moderate Buy” from the ten analysts that are currently covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation, seven have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year price objective among brokerages that have covered the stock in the last year is $20.00.

A number of equities analysts have weighed in on SHC shares. Piper Sandler raised shares of Sotera Health from a “neutral” rating to an “overweight” rating and increased their price target for the stock from $17.00 to $24.00 in a research note on Friday, January 9th. Royal Bank Of Canada started coverage on Sotera Health in a report on Thursday, January 8th. They issued an “outperform” rating and a $24.00 target price on the stock. Zacks Research upgraded Sotera Health from a “hold” rating to a “strong-buy” rating in a research note on Thursday, January 1st. JPMorgan Chase & Co. raised their price objective on Sotera Health from $14.00 to $16.00 and gave the stock a “neutral” rating in a report on Wednesday, November 5th. Finally, Barclays lifted their price objective on Sotera Health from $19.00 to $20.00 and gave the company an “overweight” rating in a research note on Wednesday, November 5th.

Insider Buying and Selling at Sotera Health

In related news, Director Gtcr Investment Xi Llc sold 12,000,000 shares of Sotera Health stock in a transaction on Monday, November 10th. The shares were sold at an average price of $15.65, for a total transaction of $187,800,000.00. Following the transaction, the director owned 29,215,301 shares in the company, valued at approximately $457,219,460.65. The trade was a 29.12% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Pincus & Co. Warburg sold 9,720,000 shares of the company’s stock in a transaction on Wednesday, December 3rd. The stock was sold at an average price of $16.33, for a total transaction of $158,727,600.00. Following the sale, the director directly owned 34,102,952 shares of the company’s stock, valued at approximately $556,901,206.16. This trade represents a 22.18% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 29,384,104 shares of company stock valued at $471,824,511 over the last ninety days. Corporate insiders own 55.12% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in SHC. Sculptor Capital LP lifted its holdings in Sotera Health by 27.2% in the 2nd quarter. Sculptor Capital LP now owns 11,500,000 shares of the company’s stock worth $127,880,000 after buying an additional 2,462,489 shares in the last quarter. Vanguard Group Inc. lifted its stake in shares of Sotera Health by 10.5% in the third quarter. Vanguard Group Inc. now owns 16,471,792 shares of the company’s stock worth $259,101,000 after acquiring an additional 1,561,282 shares in the last quarter. Voss Capital LP lifted its stake in shares of Sotera Health by 146.7% in the third quarter. Voss Capital LP now owns 1,850,000 shares of the company’s stock worth $29,100,000 after acquiring an additional 1,100,000 shares in the last quarter. Norges Bank purchased a new position in Sotera Health in the second quarter valued at about $9,607,000. Finally, Two Seas Capital LP grew its stake in Sotera Health by 21.1% during the 2nd quarter. Two Seas Capital LP now owns 4,020,867 shares of the company’s stock valued at $44,712,000 after purchasing an additional 699,731 shares in the last quarter. 91.03% of the stock is currently owned by hedge funds and other institutional investors.

Sotera Health Stock Down 2.6%

Shares of NASDAQ:SHC opened at $18.69 on Friday. The stock’s 50-day moving average price is $17.39 and its two-hundred day moving average price is $15.75. The company has a current ratio of 2.38, a quick ratio of 2.18 and a debt-to-equity ratio of 4.04. Sotera Health has a 12-month low of $9.53 and a 12-month high of $19.85. The firm has a market cap of $5.31 billion, a price-to-earnings ratio of 98.37 and a beta of 1.82.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings data on Tuesday, November 4th. The company reported $0.26 EPS for the quarter, beating analysts’ consensus estimates of $0.22 by $0.04. Sotera Health had a net margin of 4.82% and a return on equity of 43.69%. The company had revenue of $311.31 million during the quarter, compared to the consensus estimate of $303.63 million. Sotera Health has set its FY 2025 guidance at 0.810-0.860 EPS. On average, research analysts forecast that Sotera Health will post 0.61 EPS for the current year.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.